Pharmacy News

Guidelines for safely tapering patients from benzodiazepines

September 10, 2025

As you know, benzodiazepines (BZDs) are approved to treat generalized anxiety disorder, insomnia, seizures, social phobia, and panic disorder.1 Regular use of BZDs, followed by […] Read more >

Changes for Part D Measures to 2025 Measurement Year for the 2027 Star Ratings

December 11, 2024

The Centers for Medicare and Medicaid Services (CMS) finalized the addition of two new Part D measures for the 2025 measurement year. Both were developed […] Read more >

Medicare Advantage Part B step therapy enhancements effective April 1, 2024

April 1, 2024

Step therapy is a required process that applies to certain Medicare Advantage Part B prescription drugs. It requires customers to first try a preferred medication […] Read more >

How are we doing?

Please let us know what you think of the Provider Newsroom information and news.

Contact Us